Millennium Management’s Enlivex Therapeutics ENLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$686K Sell
612,200
-56,808
-8% -$63.6K ﹤0.01% 3210
2025
Q1
$649K Buy
669,008
+35,161
+6% +$34.1K ﹤0.01% 3179
2024
Q4
$742K Buy
+633,847
New +$742K ﹤0.01% 3057